GENE ONLINE|News &
Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone
In an effort to close the door on its thousands of opioid lawsuits, Walmart announced a sweeping nationwide settlement framework, agreeing to pay $3.1 billion to resolve all lawsuits by state, local, and tribal governments. The retail behemoth said the payments would significantly aid the fight against opioids. On the same day, the FDA and the Department of Health and Human Resources (HHS) published a proposal to transition naloxone, a treatment used to reverse the effects of opioid overdose, to over-the-counter medication.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
